| scholarly article | Q13442814 |
| P50 | author | Xiangdong Xue | Q47154834 |
| Ye Yuan | Q87732092 | ||
| P2093 | author name string | Yuanpei Li | |
| Randy P Carney | |||
| Tzu-Yin Lin | |||
| Zhongling Wang | |||
| Yee Huang | |||
| Xinshuai Wang | |||
| Xiaocen Li | |||
| Yixuan He | |||
| P2860 | cites work | Understanding biophysicochemical interactions at the nano-bio interface | Q23909863 |
| Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles | Q28651740 | ||
| Nanoparticle therapeutics: an emerging treatment modality for cancer | Q29615628 | ||
| Nanocarriers as an emerging platform for cancer therapy | Q29616699 | ||
| Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review | Q29617388 | ||
| Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers | Q30956736 | ||
| Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma | Q33382596 | ||
| Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection | Q33821563 | ||
| Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents | Q33851179 | ||
| A smart and versatile theranostic nanomedicine platform based on nanoporphyrin | Q34093247 | ||
| Self-assembled pH-responsive MPEG-b-(PLA-co-PAE) block copolymer micelles for anticancer drug delivery | Q34303109 | ||
| Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. | Q34535205 | ||
| Engineering cells with intracellular agent-loaded microparticles to control cell phenotype | Q35060703 | ||
| Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery | Q35108788 | ||
| Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy | Q35216251 | ||
| Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle | Q35251878 | ||
| Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties | Q35559623 | ||
| Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma. | Q35895174 | ||
| One-component nanomedicine | Q36307689 | ||
| Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles | Q36319725 | ||
| Building Nanostructures with Drugs | Q36766960 | ||
| The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect | Q37742217 | ||
| Aggregation-induced emission | Q37907889 | ||
| Functional nanomaterials for phototherapies of cancer. | Q38254668 | ||
| Zinc Oxide Nanoparticles as Adjuvant To Facilitate Doxorubicin Intracellular Accumulation and Visualize pH-Responsive Release for Overcoming Drug Resistance | Q38778862 | ||
| Peptide-drug conjugates as effective prodrug strategies for targeted delivery. | Q38883760 | ||
| WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. | Q38899864 | ||
| Drug self-delivery systems for cancer therapy | Q38987588 | ||
| Protein modified upconversion nanoparticles for imaging-guided combined photothermal and photodynamic therapy | Q39035571 | ||
| Functionalized nanoscale micelles improve drug delivery for cancer therapy in vitro and in vivo | Q39157825 | ||
| Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface | Q39207806 | ||
| Near-infrared-controlled, targeted hydrophobic drug-delivery system for synergistic cancer therapy | Q39402544 | ||
| Cytophilic fluorescent bioprobes for long-term cell tracking. | Q39524915 | ||
| Colocalization analysis in fluorescence micrographs: verification of a more accurate calculation of pearson's correlation coefficient. | Q44534141 | ||
| Aggregation-induced emission: phenomenon, mechanism and applications. | Q45929927 | ||
| Simultaneous, segregated storage of two agents in a multicompartment micelle | Q46848917 | ||
| Self-assembling prodrugs | Q47904111 | ||
| Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma | Q48264845 | ||
| Nanomaterials for cancer immunotherapy. | Q48646732 | ||
| Probe-inspired nano-prodrug with dual-color fluorogenic property reveals spatiotemporal drug release in living cells | Q48683964 | ||
| Black Phosphorus Nanosheet-Based Drug Delivery System for Synergistic Photodynamic/Photothermal/Chemotherapy of Cancer. | Q51093838 | ||
| Photophysical studies of the pheophorbide a dimer. | Q52077967 | ||
| Porphyrin–Lipid Stabilized Gold Nanoparticles for Surface Enhanced Raman Scattering Based Imaging | Q57699660 | ||
| Comparison of Methods and Achievable Uncertainties for the Relative and Absolute Measurement of Photoluminescence Quantum Yields | Q62383973 | ||
| Irinotecan is an active agent in untreated patients with metastatic colorectal cancer | Q71059673 | ||
| Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient | Q84588093 | ||
| Creation of pure nanodrugs and their anticancer properties | Q84962819 | ||
| Spatiotemporal drug release visualized through a drug delivery system with tunable aggregation-induced emission | Q86538230 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | multimodal imaging | Q66214583 |
| P304 | page(s) | 203-215 | |
| P577 | publication date | 2018-02-03 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Self-indicating, fully active pharmaceutical ingredients nanoparticles (FAPIN) for multimodal imaging guided trimodality cancer therapy | |
| P478 | volume | 161 |
| Q93235292 | A facile approach to fabricate self-assembled magnetic nanotheranostics for drug delivery and imaging |
| Q92407295 | A polymer-free, biomimicry drug self-delivery system fabricated via a synergistic combination of bottom-up and top-down approaches |
| Q92635811 | Conducting Polymeric Nanocomposites with a Three-Dimensional Co-flow Microfluidics Platform |
| Q58759696 | Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment |
Search more.